The growing uses of medicinal cannabis
Pharmaceutical Technology
MARCH 6, 2024
Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.
Pharmaceutical Technology
MARCH 6, 2024
Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 6, 2024
Tiny fragments of microplastics are making their way deep inside our bodies in concerning quantities, significantly through our food and drink. Scientists have now found a simple and effective means of removing them from water.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 6, 2024
J&J submitted a new application to the EMA for the approval of its Darzalex combination therapy for multiple myeloma.
Bio Pharma Dive
MARCH 6, 2024
Study results showed early signs of promise in Duchenne patients who are currently ineligible to receive Sarepta’s Elevidys, triggering a stock surge.
Pharmaceutical Technology
MARCH 6, 2024
Experience rapid pain relief with Sorrento Therapeutics' stable oral liquid pharmaceutical composition of celecoxib. Patent filed for effective pain management within 2 hours.
Bio Pharma Dive
MARCH 6, 2024
Incubated by RA Capital and backed by a wide array of investors, the startup is developing drugs that work differently than Vertex’s market-leading medicines.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
MARCH 6, 2024
A small partnership with Merus adds to Gilead’s string of cancer dealmaking, which, so far, has not paid off for the large biotech.
Pharmaceutical Technology
MARCH 6, 2024
Discover Avacta Group's groundbreaking patent for therapeutic conjugates with extended half-life, targeting improved efficacy in treating diseases like cancer. Learn more about this innovative approach now!
Bio Pharma Dive
MARCH 6, 2024
The startup, one of a number of young biotechs coming after Bristol Myers’ Sotyktu, will use the cash to fund a late-stage trial in plaque psoriasis.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 6, 2024
Oncologists during clinical trials of paediatric cancer cases are seen to encounter parent reluctance. Viewed as a significant challenge, cancer care centres have observed that it comes in because of hesitancy by parents to enroll their children.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Bio Pharma Dive
MARCH 6, 2024
The Barcelona-based firm, which is targeting about €100 million for the new fund, is eyeing investments in AI, synthetic biology, and cell and gene therapy.
Pharma Mirror
MARCH 6, 2024
Presented by BetterHelp. In the mental wellness space, neurodiversity can sometimes be overlooked. Although neurodivergent diagnoses differ from mental health concerns, there are often aspects of the diagnosis that can present mental health challenges for some people. For anyone diagnosed with a condition or disorder, self-esteem challenges can arise.
Pharmaceutical Technology
MARCH 6, 2024
Sonrai Analytics has entered a partnership with Candel to expedite the development of viral immunotherapies for treating cancer.
Fierce Pharma
MARCH 6, 2024
AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. | AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
MARCH 6, 2024
Ono Pharmaceutical has signed an exclusive licence agreement for the development and marketing of NEX-I’s new cancer therapy, NXI-101.
Rethinking Clinical Trials
MARCH 6, 2024
Speaker Joseph Doyle, PhD Erwin H. Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. 9% of the U.S. has the condition; it is responsible for 300,000 premature deaths/year and $330 billion in annual healthcare spending.
Pharmaceutical Technology
MARCH 6, 2024
To protect patient safety and reduce recall risks, drug manufacturers must reduce particle contamination sources wherever possible.
pharmaphorum
MARCH 6, 2024
Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer biomarker development.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
MARCH 6, 2024
Akari Therapeutics has signed an agreement with Peak Bio to merge in an all-stock transaction, creating a diversified pipeline.
pharmaphorum
MARCH 6, 2024
Looking to automate your literature search and review process in pharmacovigilance? Learn how AI can streamline the detection and analysis of Adverse Events (AE) effectively.
Pharmaceutical Technology
MARCH 6, 2024
The US Food and Drug Administration (FDA) has granted approval for Sandoz’s Wyost and Jubbonti, two biosimilars of denosumab.
Fierce Pharma
MARCH 6, 2024
GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization since 2018 as a preferred treatment for the virus. | The World Health Organization (WHO)'s latest HIV Drug Resistance report showed that some patients are developing resistance to Tivicay, which has been recommended as a preferred treatment since 2018.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
MARCH 6, 2024
Discover how Navidea Biopharmaceuticals Inc. is revolutionizing targeted drug delivery with a patent for compounds to repolarize tumor-associated macrophages and treat cancer, autoimmune disorders, and infections.
Drug Patent Watch
MARCH 6, 2024
GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN? appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
MARCH 6, 2024
Discover Kalvista Pharmaceuticals' innovative patent for on-demand treatment of bradykinin-mediated angioedema with an orally administered plasma kallikrein inhibitor. Providing easier options for patients struggling with tablet swallowing.
pharmaphorum
MARCH 6, 2024
A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector. AZ is preparing to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development and manufacturing of vaccines, including the construction of a new plant that will be powered by renewable energy, according to a government statement.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
MARCH 6, 2024
Discover Amarin Corp's groundbreaking patent for EPA and statin compositions to treat cardiovascular diseases. Learn about the innovative method and solid dosage forms outlined in the patent for optimal treatment outcomes.
pharmaphorum
MARCH 6, 2024
Sandoz has claimed the first FDA approvals for biosimilars of Amgen’s blockbuster bone disease therapy denosumab, but has not said when it plans to launch them onto the US market.
Pharmaceutical Technology
MARCH 6, 2024
Discover the innovative pharmaceutical composition patented by PTC Therapeutics Inc. to treat diseases like a-synucleinpathy and liver diseases. Learn about the specific ratios of ingredients and administration methods outlined in the patent.
BioPharma Reporter
MARCH 6, 2024
Hayley Crowe is executive vice president and general manager of Ecolabâs Global Life Sciences sector, comprised of Ecolabâs Purolite and pharma / personal care businesses. We sat down with Hayley to discuss how grief inspired her determination to make a difference and how she is helping female colleagues address their imposter syndrome and 'mental attack'.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content